Subgroup Analyses from a Phase 3, Open-Label, Randomized Study of Eribulin Mesylate Versus Capecitabine in Pretreated Patients with Advanced or Metastatic Breast Cancer
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2016-06-01
|
| Series: | Breast Cancer: Basic and Clinical Research |
| Online Access: | http://www.la-press.com/subgroup-analyses-from-a-phase-3-open-label-randomized-study-of-eribul-article-a5733 |
Search Result 1
by Chris Twelves, Ahmad Awada, Javier Cortes, Louise Yelle, Galina Velikova, Martin S. Olivo, James Song, Corina E. Dutcus, Peter A. Kaufman
Published 2016-01-01
Get full textPublished 2016-01-01
Article